Emergent BioSolutions (EBS) Tops Q2 EPS by 18c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.80 -3.13%
EPS Growth %: -138.7%
Financial Fact:
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -138.7%
Financial Fact:
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.36, $0.18 better than the analyst estimate of $0.18. Revenue for the quarter came in at $126.1 million versus the consensus estimate of $114.25 million.
Emergent BioSolutions reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Redburn upgrades Southwest, stays bullish on Delta and United
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
